Search alternatives:
infectious » infection (Expand Search)
diseases » disease (Expand Search)
Showing 1 - 20 results of 114 for search '"Infectious Diseases and Therapy"', query time: 0.08s Refine Results
  1. 1
    The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide

    The Potential Impact of Increased Recombinant Zoster Vaccine Uptake in Older Adults Worldwide by Nikolaos Giannelos, Desmond Curran, Sean Matthews, Justin Carrico, Anthony L. Cunningham

    Published 2025-05-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022–February 2023

    Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022–February 2023 by Marta Biedrzycka, Radosław Izdebski, Waleria Hryniewicz, Marek Gniadkowski, Dorota Żabicka

    Published 2025-01-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review

    The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review by Roberto Debbag, Deborah Rudin, Francesca Ceddia, John Watkins

    Published 2024-12-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Tackling CMV in Transplant Recipients: Past, Present, and Future

    Tackling CMV in Transplant Recipients: Past, Present, and Future by Tal Schlaeffer-Yosef, Lior Nesher

    Published 2025-04-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy of Topical Antifungal Nail Solution Versus Topical Placebo Solution for the Treatment of Pedal Onychomycosis: A Randomized Controlled Trial

    Efficacy of Topical Antifungal Nail Solution Versus Topical Placebo Solution for the Treatment of Pedal Onychomycosis: A Randomized Controlled Trial by Donald Scot Malay, Hye Rin Kim, Nicholas John Perfetti, Yolanda R. Marshall, Peter J. Bregman, Allysa M. Vavra

    Published 2025-05-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Detection of SARS-CoV-2 in Settings Including Point-of-Care: Performance of the Cobas SARS-CoV-2 NAT and Utility with the Cobas Liat System

    Detection of SARS-CoV-2 in Settings Including Point-of-Care: Performance of the Cobas SARS-CoV-2 NAT and Utility with the Cobas Liat System by Myrto Bolanaki, Martin Möckel, Christopher Dodoo, Karen Gilliam, Elissa Robbins, D. Jane Hata, Bruce White

    Published 2025-07-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial

    Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered with Routine Pediatric Vaccines: A European Randomized Controlled Trial by Federico Martinon-Torres, Miia M. Virta, Susanna Koski, Ignacio Salamanca de la Cueva, Henryk T. Szymanski, Samantha Bosis, Anca C. Drăgănescu, Sven-Arne Silfverdal, Betzana Zambrano, Mandeep S. Dhingra, Siham B’Chir, Olga Syrkina, Olga Lyabis, Gustavo A. Vasquez, Christine Rehm, The MET58 Study Group

    Published 2025-07-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024

    Letter to the Editor Regarding "Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination" by Albertson et al. 2024 by Ivan Pourmir, Adrian Alanis, Niccolò Clemente

    Published 2025-04-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Protective Measures Taken in Residential Care Homes in England During the COVID-19 Pandemic. An Assessment of the Change in Mortality Rates Before and During the COVID-19 Pandemic Years

    Protective Measures Taken in Residential Care Homes in England During the COVID-19 Pandemic. An Assessment of the Change in Mortality Rates Before and During the COVID-19 Pandemic... by Michael Stedman, Samuel Kitching, Martin B. Whyte, Adrian Heald

    Published 2025-06-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period

    Long-Term Real-World Use of Cabotegravir/Rilpivirine: Adherence and Virological Efficacy over a 44-Month Observation Period by Catharina Dannenberg, Hanna Matthews, Anja Hüfner, Gabriel V. Drewinski, Anna Koval, Sabine Jordan, Stefan Schmiedel, Julian Schulze zur Wiesch, Olaf Degen

    Published 2025-07-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Respiratory Syncytial Virus (RSV) as a Secondary Diagnosis among Hospitalized Patients in Germany: Outcomes and Economic Burden

    Respiratory Syncytial Virus (RSV) as a Secondary Diagnosis among Hospitalized Patients in Germany: Outcomes and Economic Burden by Markus Weinert, Jana Diekmannshemke, Kylie Braegelmann, Manuel Batram, Julian Witte, Stefan Scholz, Darshan Mehta, Bernhard Ultsch, Kristina Dobrindt, Jens Gottlieb

    Published 2025-04-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus

    Heartfelt Impact: A Descriptive Analysis of Ceftaroline-Containing Regimens in Endocarditis due to Methicillin-Resistant Staphylococcus aureus by Kaylee E. Caniff, Chloe Judd, Kristen Lucas, Sandra Goro, Caroline Orzol, Mirna Eshaya, Mohammed Al Musawa, Michael P. Veve, Michael J. Rybak

    Published 2024-11-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Syndemics of Antimicrobial Resistance: Non-communicable Diseases, Social Deprivation, and the Rise of Multidrug-Resistant Infections

    Syndemics of Antimicrobial Resistance: Non-communicable Diseases, Social Deprivation, and the Rise of Multidrug-Resistant Infections by Jacinda C. Abdul-Mutakabbir, Raheem Abdul-Mutakabbir

    Published 2025-07-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review

    Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review by Steven Shen, Jamie Findlow, Paula Peyrani

    Published 2024-11-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible?

    Is a Consensus Case Definition for Viral Associated Lower Respiratory Tract Disease (LRTD) in Clinical Trials Possible? by S. Elizabeth Williams, Bradford Gessner, Elizabeth Begier, Negar Aliabadi, Kumar Ilangovan, Luis Jodar, Cassandra Hall-Murray, Giovanni Checcucci Lisi, Edward Walsh

    Published 2024-12-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV

    Clinical Pharmacokinetics and Safety of a New HIV-1 Capsid Inhibitor, VH4004280, After Oral Administration in Adults Without HIV by Nilay Thakkar, Rulan Griesel, Amy Pierce, Veronica Bainbridge, Bronagh Shepherd, Konstantinos Angelis, Andrew Tomlinson, Yash Gandhi, Darin Brimhall, Daijha Anderson, Susan Andrews, Carolina Acuipil, Cynthia McCoig, Mark Baker, Paul Benn

    Published 2025-04-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Gender Differences in Antibiotic Prescriptions and Healthcare Visits Among Caregivers Accompanying Children with Respiratory Tract Infections: A Cross-Sectional Study

    Gender Differences in Antibiotic Prescriptions and Healthcare Visits Among Caregivers Accompanying Children with Respiratory Tract Infections: A Cross-Sectional Study by Taito Kitano, Yusuke Asai, Ryuji Koizumi, Norio Ohmagari, Shinya Tsuzuki

    Published 2025-06-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period

    Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period by Samah Hayek, Joseph Levy, Galit Shaham, Noa Dagan, Danielle Serby, Hadar Duskin-Bitan, Sabada Dube, Cátia Ferreira, Idit Livnat, Carla Talarico, Sylvia Taylor, Sudhir Venkatesan, Adva Yarden, Ran D. Balicer, Doron Netzer, Alon Peretz

    Published 2025-01-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (EON-US)

    Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (... by Corey Fang, Casey Dobie, Amita Ketkar, Monica Verduzco-Gutierrez, George Fadda, Claire Bocage, Chia Chen Jenny Teng, Raven Perez, Mark Brunk-Grady, Lisa Glasser, Christine Dube, Nadine Breslin, Vincent Willey

    Published 2025-06-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Gut Microbial Signatures in Long COVID: Potential Biomarkers and Therapeutic Targets

    Gut Microbial Signatures in Long COVID: Potential Biomarkers and Therapeutic Targets by Soyoung Oh, Sujin An, Kihyun Park, Soohyung Lee, Yoo Min Han, Seong-Joon Koh, Joowon Lee, Hyerin Gim, Donghyun Kim, Haesook Seo

    Published 2025-06-01
    “…Infectious Diseases and Therapy…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: